Illumina has partnered with Genome Medical to offer our employees and their families access to genomic education and experts through chat, phone or email. Genome Medical provides educational and health-related information that progresses the understanding of genomics and helps employees get answers on a variety of questions. General genetic questions or more detailed personalized inquiries can be answered by the Genome Medical clinical team.

The first Illumina employee sequencing program launched in 2014 and we have learned a lot since then. We have seen the marketplace for sequencing tests and screenings explode, while at the same time, employees expressed the need for education as a first step in their genomics journey. We have also witnessed the power of genetic counseling and doctor-to-doctor consultations to advance patient understanding and care. Illumina is excited to have partnered with Genome Medical to launch our workplace genomics program.

Illumina employees and their dependents (spouses/domestic partners and children) are eligible under our Genome Access program.

All other eligible family members can access the program, but the cost of the Genome Medical services will be paid by the family member.

Employees and their eligible family members outside of the U.S. can utilize educational resources available through Genome Medical, including live support and peer-to-peer consultations. Due to regulations and licensure laws related to the practice of medicine, Genome Medical genetic counselors and physicians cannot provide direct patient care to individuals outside of the U.S. However, they will support your personal physician with any questions regarding your genetic care through peer-to-peer consultation.

No. There is no waiting period required. Regular Illumina employees can take advantage of this program immediately.

Connect via chat, phone or email with a genetic expert who can address your questions here.

Genome Medical’s health care providers have ordering privileges in all 50 states in the U.S. Outside of the U.S., Genome Medical will work with your personal physician to order a genetic test or identify a local physician who can order a genetic test. Please note that additional charges may apply for local physician services.

The lab performing the test will generate a result report, which will be provided to the physician that ordered your test; this may be your personal physician or a Genome Medical physician. In addition to providing you with a copy of the lab report, Genome Medical will create a clinical action plan that provides specific recommendations for any follow-up care that is appropriate based on your genetic test result in combination with your personal and family history.

Yes. There are several different genetic testing options for employees who want to be proactive about their health. These tests may assess risks for hereditary cancer syndromes, hereditary cardiac disorders, hereditary neurologic disorders, carrier status, pharmacogenomics and more. The cost of testing can range from $250 to $2,000.

Yes. Our financial support for RUGD, Foundation Medicine and Reproductive Health continues. As a new step for employees facing rare and undiagnosed genetic diseases or cancer, Genome Medical should be their first call.

No. Illumina has decided to discontinue the TruGenome™ Predisposition Screen. Genome Medical will work with other laboratories offering whole genome, exome and proactive health genetic tests and can work with employees to choose the test that is appropriate for their individual needs. These tests are often offered at a price less than what employees would have paid for the discounted price of the TruGenome™ Predisposition Screen.

There is no cost for Illumina employees and their dependents (spouses/domestic partners and children) to access education or genetic counseling services through Genome Medical. However, employees and immediate family members will be responsible for the cost of any genetic tests with the exception of the TruGenome™ UDD Test (the test used for RUGD cases), Foundation Medicine cancer or the Galleri test – clinical eligibility requirements must be met to access these tests at no cost. When medically appropriate, genetic testing will be billed to your health insurance.

Other family members may use Genome Medical services and can self-pay. The cost of consultation may range from $179 and may be covered by their health insurance.

Employees and their dependents (spouse/domestic partner and children) will be responsible for the cost of any genetic tests with the exception of the TruGenome™ UDD Test (the test used for RUGD cases), Foundation Medicine cancer test or the Galleri multi-cancer early detection test – clinical eligibility requirements must be met to access these tests at no cost. When medically appropriate, genetic testing will be billed to your health insurance.

Illumina will directly cover the cost of the following tests if not covered by your insurance. It is available at no cost to the employee and immediate family members (children, spouse, domestic partner, parents) for UDD single or trio test. The cost for other eligible family members is $2,500. This cost includes whole genome sequencing and interpretation of the genome.

The UDD test is a genetic testing for patients with rare and undiagnosed genetic diseases (RUGD). This test is used when targeted genetic testing focused on the disease presentation has not identified a genetic cause for the patient’s symptoms and there is a belief that despite prior negative genetic testing, there may be an unidentified genetic cause. The UDD test may also be used in cases where the patient has a combinations of symptoms for which there is no clinically available genetic test. Because UDD is intended for use in rare cases and where other testing has been inconclusive, in most cases UDD will not be the first test offered.

If you or an immediate family member* has been diagnosed with cancer, Genome Medical is here to work with you, your family and your oncologist to support you through your cancer care. As an Illumina employee, you and your family members have access to Foundation Medicine testing at no charge. This testing may be used by oncologists to help determine which chemotherapies may work best to treat cancer when chemotherapy is needed. This test is often used in situations when someone is not responding to standard chemotherapies. If this Foundation Medicine testing is something that you and/or your oncologist are interested in pursuing, please contact Genome Medical at clinical@genomemedical or (877) 688-0992. We will work with your oncologist to make sure this testing is ordered and performed at no cost to yourself or your loved one.

*Family members covered by this benefit include spouses/domestic partners and children.

Illumina will directly cover the cost of the tests if not covered by your insurance. The Foundation Medicine cancer tests are available at no cost to Illumina employees and their dependents (spouses/domestic partners and children). Foundation Medicine will directly bill Illumina for the cost of the test. All other eligible family members will be referred to Foundation Medicine for pricing information and next steps.

Foundation Medicine offers the following genetic testing for patients diagnosed with cancer (not intended for healthy patients with a family history of cancer).

• FoundationOne®CDX is the first FDA-approved broad companion diagnostic with Medicare coverage for qualifying patients across all solid tumors, including: NSCLC, Colorectal, Breast, Ovarian and Melanoma. This test utilizes advanced genomic sequencing technology to provide a detailed understanding of what is driving an individual patient’s tumor at the genetic level, which can help guide a personalized treatment plan.
• FoundationOne® LIQUID is a genetic test using a simple blood sample (sometimes called a liquid biopsy). This test is appropriate for patients with solid tumors in order to help guide targeted therapy, immunotherapy and clinical trial options.
• FoundationOne® HEME is a fully informative genomic profile for blood cancers like leukemia and lymphoma, and for sarcomas. It is performed on blood, bone marrow or tissue and may help identify targeted therapy, immunotherapy or clinical trial options.

The cost of the tests may be covered under the FSA Health Care Account or Health Savings account, if the primary purpose of the test is for “diagnosis, cure, mitigation, treatment or prevention of disease.” The expense must be primarily used to alleviate or prevent a physical or mental defect or illness and not merely beneficial to general health. FSA or HSA can only be used for your immediate family members (i.e., spouse or children).

Illumina takes patient privacy seriously. Illumina, Genome Medical and the GRAIL Laboratory will maintain the health information in compliance with all applicable medical privacy laws, including HIPAA, GINA, etc. Genome Medical will not share any health information with Illumina. Use of the Genomics Resource Center is confidential.

No. Foundation Medicine does not share test results with Illumina, only with the employee’s physician.

Laboratories that operate under CLIA and CAP standards typically use samples or information to help improve quality for future patients. This includes tracking variant frequencies to help understand the potential implications of results and using information to identify regions for technical improvements. If testing is ordered through the Illumina Clinical Services Lab, no biological research is conducted using your genetic information or your samples. Every laboratory has its own policies and consent forms. If you have a test ordered through Genome Medical, your genetic counselor will discuss the testing lab’s policy on research before the test is ordered.

Yes. For more information or to connect with a genetic expert who can address your questions, click here.